Royal Bank of Canada Increases ResMed (NYSE:RMD) Price Targe

ResMed (NYSE:RMD – Free Report) had its price target raised by Royal Bank of Canada from $187.00 to $200.00 in a report issued on Friday, Benzinga reports. The firm currently has a sector perform rating on the medical equipment provider’s stock. A number of other research analysts have also recently commented on the stock. Oppenheimer […]

Related Keywords

United Kingdom , Canada , Great Lakes , Canada General , Peterc Farrell , , Resmed Company Profile , Benjaminf Edwards Company Inc , Mv Capital Management Inc , Great Lakes Advisors , Keycorp , Harfst Associates Inc , Jpmorgan Chase Co , Resmed Inc , Needham Company , Royal Bank , Gulf International Bank United Kingdom Ltd , Free Report , Moderate Buy , Med Stock Down , Get Free Report , Director Peter , General Counsel Michael , International Bank United Kingdom Ltd , Lakes Advisors , Med Inc , Respiratory Care , Resmed Daily , Resmed , Nyse Rmd , Rmd , Medical , 76115210 , Boost Price Target , Royal Bank Of Canada ,